EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges of Gene Editing Therapies for Genodermatoses

Imogen R Brooks iD, Adam Sheriff, Declan Moran, Jingbo Wang, Joanna Jacków iD

International Journal of Molecular Sciences · 24.01.2023 · 24 (3) · 2298

DOI: 10.3390/ijms24032298 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.01.2023. Verfasst von Imogen R Brooks und 4 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology, King's College London, London SE1 9RT, UK. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, CureEB Charity, EB Research Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genodermatoses encompass a wide range of inherited skin diseases, many of which are monogenic. Genodermatoses range in severity and result in early-onset cancers or life-threatening damage to the skin, and there are few curative options. As such, there is a clinical need for single-intervention treatments with curative potential. Here, we discuss the nascent field of gene editing for the treatment of genodermatoses, exploring CRISPR–Cas9 and homology-directed repair, base editing, and prime editing tools for correcting pathogenic mutations. We specifically focus on the optimisation of editing efficiency, the minimisation off-targets edits, and the tools for delivery for potential future therapies. Honing each of these factors is essential for translating gene editing therapies into the clinical setting. Therefore, the aim of this review article is to raise important considerations for investigators aiming to develop gene editing approaches for genodermatoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsGenetic TherapyMutationRecombinational DNA Repair

Stichwörter der Autor:innen

CRISPRbase editinggene editinggene editing strategiesgenetic skin diseasegenodermatosesoff-targetsprime editing

Autor:innen und Institutionen

  • St John's Institute of Dermatology, King's College London, London SE1 9RT, UK.

ORCID-Profile: Imogen R Brooks, Joanna Jacków

Förderung

  • Wellcome Trust
  • CureEB Charity
  • EB Research Partnership
  • EB Medical Research Foundation

Zitieren

APA

Brooks, I. R., Sheriff, A., Moran, D., Wang, J., & Jacków, J. (2023). Challenges of Gene Editing Therapies for Genodermatoses. International Journal of Molecular Sciences, 24(3), 2298. https://doi.org/10.3390/ijms24032298

Vancouver

Brooks IR, Sheriff A, Moran D, Wang J, Jacków J. Challenges of Gene Editing Therapies for Genodermatoses. International Journal of Molecular Sciences. 2023;24(3):2298. doi:10.3390/ijms24032298

BibTeX
@article{Brooks2023,
  author = {Brooks, Imogen R and Sheriff, Adam and Moran, Declan and Wang, Jingbo and Jacków, Joanna},
  title = {Challenges of Gene Editing Therapies for Genodermatoses},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2298},
  doi = {10.3390/ijms24032298}
}
Kostenlos starten →